Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.72−0.03 (-1.71%)
Close on Nov 17, 2026Market cap $36.18MP/E –Yield –
Grace Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Grace Therapeutics's market cap was $30.19M on Nov 11, 2026, against $44.93M a year earlier. Over the last 5 years it ranged from $15.32M to $71.64M, with a median of $31.57M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $30.19M | -38.2% |
| 2025 | Dec 31, 2025 | $48.88M | +15.1% |
| 2024 | Dec 31, 2024 | $42.48M | +96.5% |
| 2023 | Dec 29, 2023 | $21.61M | -15.1% |
| 2022 | Dec 30, 2022 | $25.45M | -14.9% |
| 2021 | Dec 31, 2021 | $29.90M | -0.0% |
| 2020 | Dec 31, 2020 | $29.90M | +218.6% |
| 2019 | Apr 30, 2019 | $9.39M | +4.6% |
| 2018 | Dec 31, 2018 | $8.97M | -11.8% |
| 2017 | Dec 29, 2017 | $10.17M | -23.7% |
| 2016 | Dec 30, 2016 | $13.32M | – |
See a number that looks wrong?